Virtus Respiratory Research Limited

VirTus Respiratory Research Ltd, based in Bristol, UK, is a small, active company founded six years ago in 2018. With four employees and £1,406,099 in assets, it operates from a virtual address – a point of interest given that eighty-two companies are registered at the same location. The company is led by two directors and has one owner, Professor Sebastian Johnston, who also serves as Chief Medical Officer. It has a stellar 5.0 Google rating based on a single review. VirTus regularly imports miscellaneous chemical products, with the most recent import activity recorded four months ago.

The company’s website highlights its role as a world-leading contract research organisation specialising in respiratory drug development. It describes itself as having an “academic brain with a contract research organisation’s body,” offering preclinical and human challenge trials. VirTus partners with institutions like Imperial College NHS Healthcare Trust, providing innovative technologies and flexible services, including clinical trial management, vaccine and antiviral research, and laboratory services. The website also features a section for volunteers participating in clinical research trials.

Financially, VirTus shows a mixed picture. Cash bank holdings increased significantly by 110%, reaching £1.1 million, while current assets also saw a substantial rise of 150% to £1.4 million. However, trade debtors have ballooned by an impressive 2,500%, reaching £270,000—a potential sign of delayed payments or an expansion of credit terms. Net assets also increased by 140% to £1.5 million. Property plant and equipment also increased by 19%, and depreciation charges remained consistent. The company’s small size (meeting two of three conditions for being a small company) helps it stay agile. With no auditor mentioned, the financial statements are unaudited.

Overall, VirTus Respiratory Research Ltd appears to be growing, but the significant increase in trade debtors warrants close monitoring. The company’s focus on respiratory research and its partnerships with leading institutions suggest a promising future, but managing cash flow will be crucial for sustained success.

Registered in England/Wales under the registration number 11572125, with a registered address at BS37 6AG, United Kingdom, Bristol, Gowran House 56 Broad Street, Chipping Sodbury.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.